Malaria.com is delighted to present this latest e-issue in partnership with WWARN (the WorldWide Antimalarial Resistance Network). WWARN focuses on gathering data and collating resources related to malaria medication, and specifically factors affecting its efficacy.
One on-going effort relates to monitoring of drug quality – as one of the critical tools used for malaria control (along with long-lasting insecticide treated bednets, improved diagnostic tools, and vector control), it is extremely important that people have access to malaria medication that is appropriate and effective, both in terms of treating the patient but also not driving drug resistance in the parasite.
This e-issue focuses on the topic of drug quality in malaria medication. The series of articles, written by our collaborators at WWARN, describe the challenges related to the widespread distribution of falsified and sub-standard antimalarials, as well as various efforts dedicated to tackling the issue and ensuring global access to effective medications: